Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

The random card sort method and respondent certainty in contingent valuation: an exploratory investigation of range bias.

Shackley P, Dixon S.

Health Econ. 2014 Oct;23(10):1213-23. doi: 10.1002/hec.2980. Epub 2013 Aug 6.

PMID:
23922327
[PubMed - in process]
2.

Cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A: results from the botulinum toxin for the upper limb after stroke (BoTULS) trial.

Shackley P, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford GA, Steen N, Rodgers H.

Toxins (Basel). 2012 Dec;4(12):1415-26.

PMID:
23342679
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Putting a value on the avoidance of false positive results when screening for inherited metabolic disease in the newborn.

Dixon S, Shackley P, Bonham J, Ibbotson R.

J Inherit Metab Dis. 2012 Jan;35(1):169-76. doi: 10.1007/s10545-011-9354-0. Epub 2011 May 27.

PMID:
21617925
[PubMed - indexed for MEDLINE]
4.

Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial: effect on impairment, activity limitation, and pain.

Shaw LC, Price CI, van Wijck FM, Shackley P, Steen N, Barnes MP, Ford GA, Graham LA, Rodgers H; BoTULS Investigators.

Stroke. 2011 May;42(5):1371-9. doi: 10.1161/STROKEAHA.110.582197. Epub 2011 Mar 17.

PMID:
21415398
[PubMed - indexed for MEDLINE]
Free Article
5.

The social value of a QALY: raising the bar or barring the raise?

Donaldson C, Baker R, Mason H, Jones-Lee M, Lancsar E, Wildman J, Bateman I, Loomes G, Robinson A, Sugden R, Prades JL, Ryan M, Shackley P, Smith R.

BMC Health Serv Res. 2011 Jan 11;11:8. doi: 10.1186/1472-6963-11-8.

PMID:
21223540
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Weighting and valuing quality-adjusted life-years using stated preference methods: preliminary results from the Social Value of a QALY Project.

Baker R, Bateman I, Donaldson C, Jones-Lee M, Lancsar E, Loomes G, Mason H, Odejar M, Pinto Prades JL, Robinson A, Ryan M, Shackley P, Smith R, Sugden R, Wildman J; SVQ Research Team.

Health Technol Assess. 2010 May;14(27):1-162. doi: 10.3310/hta14270.

PMID:
20525460
[PubMed - indexed for MEDLINE]
Free Article
7.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

PMID:
20515600
[PubMed - indexed for MEDLINE]
Free Article
8.

Assessing current health-related quality of life questionnaires administered to patients with venous ulcers: can they be used in economic evaluations?

Palfreyman SJ, Shackley P, Brazier JE.

J Clin Nurs. 2010 Mar;19(5-6):892-7. doi: 10.1111/j.1365-2702.2009.03172.x. Review. No abstract available.

PMID:
20500332
[PubMed - indexed for MEDLINE]
9.

A prospective randomised controlled trial and economic modelling of antimicrobial silver dressings versus non-adherent control dressings for venous leg ulcers: the VULCAN trial.

Michaels JA, Campbell WB, King BM, Macintyre J, Palfreyman SJ, Shackley P, Stevenson MD.

Health Technol Assess. 2009 Nov;13(56):1-114, iii. doi: 10.3310/hta13560.

PMID:
19939335
[PubMed - indexed for MEDLINE]
Free Article
10.

Randomized controlled trial and cost-effectiveness analysis of silver-donating antimicrobial dressings for venous leg ulcers (VULCAN trial).

Michaels JA, Campbell B, King B, Palfreyman SJ, Shackley P, Stevenson M.

Br J Surg. 2009 Oct;96(10):1147-56. doi: 10.1002/bjs.6786.

PMID:
19787753
[PubMed - indexed for MEDLINE]
11.

Evaluation of the cost-effectiveness of root canal treatment using conventional approaches versus replacement with an implant.

Pennington MW, Vernazza CR, Shackley P, Armstrong NT, Whitworth JM, Steele JG.

Int Endod J. 2009 Oct;42(10):874-83. doi: 10.1111/j.1365-2591.2009.01582.x.

PMID:
19751289
[PubMed - indexed for MEDLINE]
12.

Study design and methods of the BoTULS trial: a randomised controlled trial to evaluate the clinical effect and cost effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Rodgers H, Shaw L, Price C, van Wijck F, Barnes M, Graham L, Ford G, Shackley P, Steen N; BoTULS Investigators.

Trials. 2008 Oct 23;9:59. doi: 10.1186/1745-6215-9-59.

PMID:
18947418
[PubMed]
Free PMC Article
13.

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR.

Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134.

PMID:
17903391
[PubMed - indexed for MEDLINE]
Free Article
14.

A comparison of the 'cost per child treated' at a primary care-based sedation referral service, compared to a general anaesthetic in hospital.

Jameson K, Averley PA, Shackley P, Steele J.

Br Dent J. 2007 Sep 22;203(6):E13. Epub 2007 Jul 13.

PMID:
17632457
[PubMed - indexed for MEDLINE]
15.

The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group.

Lancet. 2007 Mar 24;369(9566):1016-26.

PMID:
17382828
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, Cramp C, Cockerell OC, Cooper PN, Doughty J, Eaton B, Gamble C, Goulding PJ, Howell SJ, Hughes A, Jackson M, Jacoby A, Kellett M, Lawson GR, Leach JP, Nicolaides P, Roberts R, Shackley P, Shen J, Smith DF, Smith PE, Smith CT, Vanoli A, Williamson PR; SANAD Study group.

Lancet. 2007 Mar 24;369(9566):1000-15.

PMID:
17382827
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Preferences for access to the GP: a discrete choice experiment.

Rubin G, Bate A, George A, Shackley P, Hall N.

Br J Gen Pract. 2006 Oct;56(531):743-8.

PMID:
17007703
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Implicit versus explicit ranking: on inferring ordinal preferences for health care programmes based on differences in willingness-to-pay.

Olsen JA, Donaldson C, Shackley P; EuroWill Group.

J Health Econ. 2005 Sep;24(5):990-6.

PMID:
15893827
[PubMed - indexed for MEDLINE]
19.

Willingness to pay for public health care: a comparison of two approaches.

Olsen JA, Kidholm K, Donaldson C, Shackley P.

Health Policy. 2004 Nov;70(2):217-28.

PMID:
15364151
[PubMed - indexed for MEDLINE]
20.

The impact of information on non-health attributes on willingness to pay for multiple health care programmes.

Protière C, Donaldson C, Luchini S, Moatti JP, Shackley P.

Soc Sci Med. 2004 Apr;58(7):1257-69.

PMID:
14759674
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk